glp-1 regulation and Microbiome Repair for Long-Term Metabolism Glucagon-like peptide 1 (GLP-1) -

By activating both of these receptors, tirzepatide promotes weight loss more effectively than traditional treatments targeting only the GLP-1 receptor

Addressing Metabolic Dysfunction as an Independent Cancer Risk Factor Accumulating evidence positions metabolic dysfunction characterised by insulin resistance, hepatic steatosis, dyslipidaemia, and visceral adiposity as a more powerful and proximate predictor of cancer risk than elevated body weight alone

Phase I and II clinical trials corroborate these findings, showing dose-dependent weight loss, reductions in Glycated Hemoglobin (HbA1c) levels, and improvements in liver steatosis and diabetic kidney disease

Gastroenterology | ACG

As a result, much of the GLP-1 in intestinal veins is already degraded (46)